Four opposition parties jointly submitted a bill Friday to the Lower House that would greatly reduce medical costs that hepatitis B and C patients need to shoulder for expensive interferon treatment and antiviral medication.
Last April, the government started subsidizing the interferon treatment for hepatitis B and C patients after admitting responsibility for approving tainted blood products that further spread the already rampant diseases in Japan.
Unable to view this article?
This could be due to a conflict with your ad-blocking or security software.
Please add japantimes.co.jp and piano.io to your list of allowed sites.
If this does not resolve the issue or you are unable to add the domains to your allowlist, please see this support page.
We humbly apologize for the inconvenience.
In a time of both misinformation and too much information, quality journalism is more crucial than ever.
By subscribing, you can help us get the story right.
SUBSCRIBE NOW
With your current subscription plan you can comment on stories. However, before writing your first comment, please create a display name in the Profile section of your subscriber account page.